Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Why Shares of C3.ai Stock Fell 27.8% in February

2 months ago 45

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Shares of C3.ai (NYSE: AI) fell an astonishing 27.8% in February, according to data from S&P Global Market Intelligence. A company that markets itself as an enterprise artificial intelligence (AI) operator, the business is clearly not benefiting from the AI revolution so far, as revenue has begun to move in the wrong direction, alongside terrible profit margins. The stock is down over 90% from its highs set right after it went public in late 2020.

Here's why the stock was falling in February, and whether you should finally buy the dip on C3.ai stock for your portfolio.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Management pitches C3.ai as a similar player to Palantir Technologies, selling custom AI services to enterprises to help them become better at what they do. The problem is, it doesn't seem to be very good at it.

Revenue was a measly $53 million last quarter, down from $99 million in the same period a year ago. We are supposedly in a revolution of AI applications taking over the world, and yet C3.ai's revenue has almost been cut in half compared to a year prior. This shows that customers are not taking to its custom software products, leading to contract non-renewals.

The company is unsurprisingly highly unprofitable. Operating loss was $140 million last quarter, more than double topline revenue. Free cash flow was negative $126 million over the last twelve months, which is going to eat into cash reserves on the balance sheet.

A brain with a bunch of digital orange icons floating around it.

Image source: Getty Images.

A true AI company like Palantir can grow while generating solid profits. Its revenue was $4.47 billion in 2025, along with over $2 billion in free cash flow. As a primary competitor to C3.ai, there is a huge disparity between these two businesses and how they are attacking the enterprise AI market.

Now, C3.ai trades at a lower-looking price-to-sales ratio (P/S) of 4, its lowest level in history. However, a company that keeps losing money with declining revenue is never going to be worth anything, no matter how low the stock falls. This should keep any investor away from this stock, even after its 28% collapse last month.

Look for better AI stocks to buy for your portfolio right now. C3.ai is not worth buying the dip on.

Before you buy stock in C3.ai, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and C3.ai wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway